Grant, Philip M <br/><br/>
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.  [electronic resource] 

 -  HIV clinical trials   
 - 284-91 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct1406-284  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--administration & dosage<br/>Adult<br/>Anti-HIV Agents--administration & dosage<br/>CD4 Lymphocyte Count<br/>Deoxycytidine--administration & dosage<br/>Dideoxynucleosides--therapeutic use<br/>Drug Combinations<br/>Drug Therapy, Combination<br/>Emtricitabine<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Lamivudine--therapeutic use<br/>Male<br/>Middle Aged<br/>Organophosphonates--administration & dosage<br/>Tenofovir<br/>Viral Load